WALTHAM, Mass. – January 6 , 2015 – X-Chem, Inc., a privately held biotechnology company applying its cutting-edge lead discovery capabilities to the generation of novel small molecule therapeutics, announced a multi-target collaboration with Sanofi. The collaboration is focused on the potential development of several programs for treatments in therapeutic areas such as oncology, rare […]
WALTHAM, Mass. – January 6, 2016 –X-Chem, Inc., a privately held biotechnology company with a proprietary and innovative platform to generate small molecule therapeutics, today announced a multi-target agreement with The University of Texas MD Anderson Cancer Center […]
WALTHAM, Mass. – January 6, 2016 –X-Chem announced today that it has been spun out to the shareholders of the parent company of Pharmaceutical Product Development, LLC (“PPD”) as an independent, privately-owned biotechnology company.